Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Hodgkin Disease × Dextromethorphan × Clear all

Phase

Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Solid Tumor 1 Neoplasm Metastasis 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Hodgkin Disease 1 Healthy Participants 1 Advanced Solid Tumor 1 Adult Solid Neoplasm 1

Interventions

Cyclophosphamide 22 fludarabine phosphate 20 Filgrastim 14 Rituximab 13 fludarabine 12 Gemcitabine 12 Vorinostat 11 Peripheral Blood Stem Cell Transplantation 11 Brentuximab Vedotin 11 Whole-Body Irradiation 10 Tacrolimus 9 Melphalan 9 Etoposide 9 Sirolimus 8 Lenalidomide 8 Busulfan 8 Bortezomib 8 Azacitidine 8 Nivolumab 7 Mycophenolic Acid 7 pembrolizumab 6 romidepsin 5 aldesleukin 5 Radiotherapy 5 Panobinostat 5 Doxorubicin 5 Dexamethasone 5 Cytarabine 5 Cyclosporine 5 Bendamustine Hydrochloride 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06383338 2025-09-08

PEGASUS

Murdoch Childrens Research Institute

Phase 1 Recruiting

Hodgkin Disease, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡